Artivion Inc AORT

NYS: AORT | ISIN: US2289031005   2/06/2023
15,29 USD (+3,52%)
(+3,52%)   2/06/2023

23 mei 2023 · Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter · Persbericht

4 mei 2023 · Artivion Reports First Quarter 2023 Financial Results · Persbericht

20 april 2023 · Artivion Announces Release Date and Teleconference Call Details for First Quarter 2023 Financial Results · Persbericht

10 april 2023 · Artivion to Participate in the 22nd Annual Needham Virtual Healthcare Conference · Persbericht

6 maart 2023 · Artivion to Participate in the Oppenheimer 33rd Annual Healthcare Conference · Persbericht

16 februari 2023 · Artivion Reports Fourth Quarter and Full Year 2022 Financial Results · Persbericht

2 februari 2023 · Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results · Persbericht

8 november 2022 · Artivion to Participate in Upcoming Investor Conferences · Persbericht

3 november 2022 · Artivion Reports Third Quarter 2022 Financial Results · Persbericht

20 oktober 2022 · Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2022 Financial Results · Persbericht

29 september 2022 · Elizabeth Hoff Joins Artivion Board of Directors · Persbericht

23 september 2022 · Artivion Follows Recommendation to Stop PROACT Xa Clinical Trial · Persbericht

14 september 2022 · Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference · Persbericht

6 september 2022 · Artivion to Participate in Upcoming Investor Conferences · Persbericht

24 augustus 2022 · Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase · Persbericht

4 augustus 2022 · Artivion Reports Second Quarter 2022 Financial Results · Persbericht

3 augustus 2022 · Artivion to Participate in Upcoming Investor Conferences · Persbericht

27 juli 2022 · Artivion Initiates Enrollment in PERSEVERE Clinical Trial · Persbericht

21 juli 2022 · Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2022 Financial Results · Persbericht

18 januari 2022 · CryoLife Announces Corporate Rebranding and Changes Name to Artivion · Persbericht

Mijn selecties